Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Silver dressing proves safe for tough wounds in new study

NCT ID NCT05690685

Disease control Sponsor: Advanced Medical Solutions Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at a silver alginate wound dressing (Silvercel) in 56 adults with chronic or acute wounds that were infected or at high risk. Over 6 weeks, doctors checked wound healing and any side effects. The goal was to confirm the dressing is safe and works as intended.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Silver alginate wound dressing (Silvercel)
What this could lead to
If successful, this confirms the dressing is safe and effective for managing wounds with infection risk or heavy drainage.
What could go wrong
This is a small, completed post-market study with only 56 participants, so results may not apply to all wound types or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

56 people

The number who actually took part.

Started

May 2023

Finished

Jul 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Males or females, age 18 years or above. (Females must not be pregnant and if of reproductive age should provide a negative pregnancy test at screening). 2. Patients who are able to understand and give informed consent to take part in the study. 3. Have one or more of the following: Pressure ulcer or Donor site wounds that are infected, or are at high risk of infection (in the opinion of the Investigator), that are moderate to heavy levels of exudate. 4. Pressure ulcers that are moderate to high exudate, typically Category 3 and 4. 5. Only one primary wound may be treated per patient for the study. Exclusion Criteria: 1. Patients who are known to be non-compliant with medical treatment, 2. Patients who are known to be sensitive to any of the device components 3. Subject is pregnant or actively breastfeeding; 4. Subject has a known sensitivity to Silver; 5. Life expectancy of \<6 months; 6. Subject has any significant or unstable medical or psychiatric condition that, in the opinion of the Investigator, would interfere with his/her ability to participate in the study; 7. Subject is currently enrolled in another clinical study, or has completed a clinical study less than 30 days prior to enrolment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pressure ulcer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

decubitus ulcer injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Wound

Contacts and locations

Locations

  • Queen Victoria Hospital

    East Grinstead, United Kingdom

  • Royal United Hospital Bath

    Bath, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.